Carolyn M Rutter1, James E Savarino. 1. Group Health Research Institute, 1630 Minor Avenue, Seattle, WA 98101, USA. rutter.c@ghc.org
Abstract
BACKGROUND: The Colorectal Cancer Simulated Population model for Incidence and Natural history (CRC-SPIN) is a new microsimulation model for the natural history of colorectal cancer that can be used for comparative effectiveness studies of colorectal cancer screening modalities. METHODS: CRC-SPIN simulates individual event histories associated with colorectal cancer, based on the adenoma-carcinoma sequence: adenoma initiation and growth, development of preclinical invasive colorectal cancer, development of clinically detectable colorectal cancer, death from colorectal cancer, and death from other causes. We present the CRC-SPIN structure and parameters, data used for model calibration, and model validation. We also provide basic model outputs to further describe CRC-SPIN, including annual transition probabilities between various disease states and dwell times. We conclude with a simple application that predicts the impact of a one-time colonoscopy at age 50 on the incidence of colorectal cancer assuming three different operating characteristics for colonoscopy. RESULTS: CRC-SPIN provides good prediction of both the calibration and the validation data. Using CRC-SPIN, we predict that a one-time colonoscopy greatly reduces colorectal cancer incidence over the subsequent 35 years. CONCLUSIONS: CRC-SPIN is a valuable new tool for combining expert opinion with observational and experimental results to predict the comparative effectiveness of alternative colorectal cancer screening modalities. IMPACT: Microsimulation models such as CRC-SPIN can serve as a bridge between screening and treatment studies and health policy decisions by predicting the comparative effectiveness of different interventions. As such, it is critical to publish model descriptions that provide insight into underlying assumptions along with validation studies showing model performance. (c)2010 AACR.
BACKGROUND: The Colorectal Cancer Simulated Population model for Incidence and Natural history (CRC-SPIN) is a new microsimulation model for the natural history of colorectal cancer that can be used for comparative effectiveness studies of colorectal cancer screening modalities. METHODS: CRC-SPIN simulates individual event histories associated with colorectal cancer, based on the adenoma-carcinoma sequence: adenoma initiation and growth, development of preclinical invasive colorectal cancer, development of clinically detectable colorectal cancer, death from colorectal cancer, and death from other causes. We present the CRC-SPIN structure and parameters, data used for model calibration, and model validation. We also provide basic model outputs to further describe CRC-SPIN, including annual transition probabilities between various disease states and dwell times. We conclude with a simple application that predicts the impact of a one-time colonoscopy at age 50 on the incidence of colorectal cancer assuming three different operating characteristics for colonoscopy. RESULTS: CRC-SPIN provides good prediction of both the calibration and the validation data. Using CRC-SPIN, we predict that a one-time colonoscopy greatly reduces colorectal cancer incidence over the subsequent 35 years. CONCLUSIONS: CRC-SPIN is a valuable new tool for combining expert opinion with observational and experimental results to predict the comparative effectiveness of alternative colorectal cancer screening modalities. IMPACT: Microsimulation models such as CRC-SPIN can serve as a bridge between screening and treatment studies and health policy decisions by predicting the comparative effectiveness of different interventions. As such, it is critical to publish model descriptions that provide insight into underlying assumptions along with validation studies showing model performance. (c)2010 AACR.
Authors: Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck Journal: Ann Intern Med Date: 2008-12-15 Impact factor: 25.391
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer Journal: Gastroenterology Date: 2008-02-08 Impact factor: 22.682
Authors: Perry J Pickhardt; Cesare Hassan; Andrea Laghi; Angelo Zullo; David H Kim; Sergio Morini Journal: Cancer Date: 2007-06-01 Impact factor: 6.860
Authors: Thomas F Imperiale; Elizabeth A Glowinski; Ching Lin-Cooper; Gregory N Larkin; James D Rogge; David F Ransohoff Journal: N Engl J Med Date: 2008-09-18 Impact factor: 91.245
Authors: Iris Lansdorp-Vogelaar; Roman Gulati; Angela B Mariotto; Clyde B Schechter; Tiago M de Carvalho; Amy B Knudsen; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk; Chester Pabiniak; Marjolein van Ballegooijen; Carolyn M Rutter; Karen M Kuntz; Eric J Feuer; Ruth Etzioni; Harry J de Koning; Ann G Zauber; Jeanne S Mandelblatt Journal: Ann Intern Med Date: 2014-07-15 Impact factor: 25.391
Authors: Marjolein van Ballegooijen; Carolyn M Rutter; Amy B Knudsen; Ann G Zauber; James E Savarino; Iris Lansdorp-Vogelaar; Rob Boer; Eric J Feuer; J Dik F Habbema; Karen M Kuntz Journal: Med Decis Making Date: 2011-06-14 Impact factor: 2.583
Authors: Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano Journal: Med Decis Making Date: 2017-05-10 Impact factor: 2.583
Authors: Fernando Alarid-Escudero; Eline M Krijkamp; Petros Pechlivanoglou; Hawre Jalal; Szu-Yu Zoe Kao; Alan Yang; Eva A Enns Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Carolyn M Rutter; Amy B Knudsen; Tracey L Marsh; V Paul Doria-Rose; Eric Johnson; Chester Pabiniak; Karen M Kuntz; Marjolein van Ballegooijen; Ann G Zauber; Iris Lansdorp-Vogelaar Journal: Med Decis Making Date: 2016-01-08 Impact factor: 2.583
Authors: Carolyn M Rutter; Jane J Kim; Reinier G S Meester; Brian L Sprague; Emily A Burger; Ann G Zauber; Mehmet Ali Ergun; Nicole G Campos; Chyke A Doubeni; Amy Trentham-Dietz; Stephen Sy; Oguzhan Alagoz; Natasha Stout; Iris Lansdorp-Vogelaar; Douglas A Corley; Anna N A Tosteson Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-11-17 Impact factor: 4.254
Authors: Jane J Kim; Anna Na Tosteson; Ann G Zauber; Brian L Sprague; Natasha K Stout; Oguzhan Alagoz; Amy Trentham-Dietz; Katrina Armstrong; Sandi L Pruitt; Carolyn M Rutter Journal: J Natl Cancer Inst Date: 2015-11-03 Impact factor: 13.506